Africa News Line Monday, 12.30.2024, 8:26 PM
Welcome Guest | RSS
Site menu

Main » 2017 » November » 19 » Julphar’s Board of Directors Meeting Held On 9th November 2017
4:30 PM
Julphar’s Board of Directors Meeting Held On 9th November 2017

 

Ras Al Khaimah, United Arab Emirates -Sunday, November 19th 2017 [ AETOS Wire ]

During the meeting held on 9th November 2017, Julphar Board of Directors released the company’s quarterly results and discussed the business achievements for the first nine months of 2017.

The Board acknowledged opportunities and challenges that have been impacting the Middle East and North Africa (MENA) region lately. The Board also evaluated the results of the first three quarters, the company achieving sales amounting to AED 992 million with a net profit of AED 86 million in this period.

As well, the Board took note of the actions already initiated to ensure that Julphar is in the right shape for further growth before year-end closing and to achieve Julphar 2020 roadmap.

Commenting on the results, Julphar’s General Manager, Jerome Carle, said: “In the third quarter, Julphar has taken further its previous achievements and has been consolidating its path to closing the year in a better position. In spite of the fast-changing market environment and the overall regional situation that impact the industry, Julphar has gained share and momentum in our core markets”.

“Julphar’s newly launched products, along with other major brands, demonstrated again their leading position. The promising results in the UAE and Levant markets have helped us consolidate our regional footprint, while the new markets in Africa will diversify our presence and add to our growth” added Jerome Carle.

About Julphar

Established in 1980, Julphar is one of the largest pharmaceutical manufacturers in Middle East and North Africa, producing over 200 branded products across 16 facilities. Julphar’s mission is to offer high quality medicines at affordable prices. Our product portfolio includes Biotechnology, Wound and Women Care, Adult and Pediatric General Medicines, Gastro and Pain Management, Cardio-Metabolism, Diabetes Solutions and Consumer range. Julphar employs more than 3,000 people around the world and registered revenue of AED 1.45 billion in 2016. For more information, please visit http://www.julphar.net.

Contacts

Julphar

Lama Mohanna, Communication Coordinator

M +971501740731, T +97172461461, D +97172045722

lama.mohanna@julphar.ne

 

Views: 225 | Added by: uaeonlinenews | Rating: 0.0/0
Total comments: 0
Name *:
Email *:
Code *:
Search

Entries archive

Calendar